|
Infectious diseases / Corrigendum
Cross-neutralizing antibody responses among individuals with or without bivalent vaccine: a six-month prospective cohort study
Hye Hee Cha, Ji Yeun Kim, Seung Beom Kim, Junho Cha, Ji-Soo Kwon, Woori Kim, Ju Yeon Son, Choi Young Jang, Min-Chul Kim, So Yun Lim, Sung-Han Kim
Korean J Intern Med. 2026;41(6):1160-1160. Published online November 1, 2026
|
|
|
Infectious diseases / Original Article
Cross-neutralizing antibody responses among individuals with or without bivalent vaccine: a six-month prospective cohort study
Hye Hee Cha, Ji Yeun Kim, Seung Beom Kim, Junho Cha, Ji-Soo Kwon, Woori Kim, Ju Yeon Son, Choi Young Jang, Min-Chul Kim, So Yun Lim, Sung-Han Kim
Korean J Intern Med. 2026;41(3):516-523. Published online May 1, 2026
Background/Aims: Although the COVID-19 pandemic has officially ended, SARS-CoV-2 continues to circulate with periodic surges and may exhibit seasonal patterns. Understanding the importance of prompt immunization, particularly in individuals with prior infection, is crucial for developing future vacc..
|
|
|
Infectious diseases / Original Article
Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19
Ji Yeun Kim, Ji-Soo Kwon, Hye Hee Cha, So Yun Lim, Seongman Bae, Sung-Han Kim
Korean J Intern Med. 2022;37(6):1234-1240. Published online October 11, 2022
Background/Aims: The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19). We therefore compared the timing of adequate ..
|
|
|
Infectious diseases / Original Article
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19
Hye Hee Cha, So Yun Lim, Ji-Soo Kwon, Ji Yeun Kim, Seongman Bae, Jiwon Jung, Sung-Han Kim
Korean J Intern Med. 2022;37(2):455-459. Published online February 28, 2022
Background/Aims: Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are limited.
Methods: Blood samples from adult p..
|
|
|
